- Monthly plan
- $199 before first-order discount
- Three month plan
- $175/month equivalent; $525 before promotion
Start with the ordinary monthly option
Effecty currently lists the NAD+ injection monthly plan at $199 before its first-order promotion. That is the figure used in our product comparison, because it gives a clearer starting point than the approximate $142 headline attached to a discounted, longer commitment. The page also shows separate three-, six- and twelve-month plans.
These are commercial supply and billing choices. They do not specify an injection regimen or determine how much medication an individual needs. The actual preparation, quantity and directions depend on the clinical evaluation and pharmacy label. We reviewed the plan page and rendered pricing without completing intake or buying treatment.
Reconstruct the introductory arithmetic
The three-month option is displayed at a $175 monthly equivalent, billed every three months, with $100 off the first order. On that basis, the undiscounted period is $525 and the introductory period is $425. Dividing the latter by three gives approximately $141.67, explaining the rounded headline. Confirm the total at checkout because this calculation is based on the advertised schedule.
The six-month and annual options show $165 and $160 monthly equivalents. Their full-period amounts before promotions would be $990 and $1,920. A lower equivalent therefore comes with more money committed at once. It is not a promise of greater benefit or a reason to accept a longer clinical plan than the prescriber considers appropriate.
Included support still needs a defined scope
Effecty says its plans include supplies, free shipping, prescription access if eligible and ongoing medical support, with no membership fee. It describes an online questionnaire and licensed-provider review. This gives the reader more to compare than a vial price alone, while leaving the actual medication quantity and follow-up arrangements to confirm.
Ask which pharmacy dispenses the injection, how shipments are scheduled and what happens if the plan changes before a prepaid period ends. A support channel advertised as continuously available does not establish an immediate clinician response. Clarify the distinction between billing assistance, medical messaging and urgent care instructions before relying on the service.
Assess the preparation and the claim separately
FDA explains that compounded drugs are not approved for safety, effectiveness or quality before marketing. Its NAD+ notice also addresses the risk of unsuitable ingredients in sterile preparations. We did not independently examine Effecty's pharmacy controls or batch records, so this review cannot certify the quality of a dispensed vial.
The provider's statements about energy, metabolism and healthy aging remain marketing claims. We did not verify a controlled study of this finished injectable product demonstrating those outcomes. Discuss the intended purpose, evidence and reasonable alternatives with the clinician instead of using a large introductory discount as a substitute for that conversation.
How to make the comparison useful
For a short commitment, compare the $199 monthly listing with other explicitly monthly offers and record any confirmed extra charges. For a longer commitment, compare the total due and cancellation terms as well as the equivalent monthly amount. Keep first-order discounts in their own column rather than treating them as perpetual savings.
Effecty's injection plan is comparatively easy to map across billing intervals. Its remaining uncertainties concern the dispensed product and the conditions attached to stopping or changing care. The nasal offering has a separate review because matching plan prices do not make the two routes clinically equivalent or establish identical package contents.
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.